Thrombin generation decrease after LMWH administration in an antithrombin-deficient pregnant woman with a homozygous HBS II mutation

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F23%3A00013566" target="_blank" >RIV/00023736:_____/23:00013566 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/23:10469185 RIV/00064165:_____/23:10469185
Result on the web
<a href="https://doi.org/10.1177/10760296231197174" target="_blank" >https://doi.org/10.1177/10760296231197174</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1177/10760296231197174" target="_blank" >10.1177/10760296231197174</a>

Result language
angličtina
Original language name
Thrombin generation decrease after LMWH administration in an antithrombin-deficient pregnant woman with a homozygous HBS II mutation
Original language description
The cases of antithrombin (AT)-deficient pregnant women with a homozygous HBS II mutation are relatively rare and are accompanied by an increased thrombophilic risk, which is manifested by increased thrombin generation (TG). It is very difficult to ensure their prophylactic treatment during pregnancy. Consistent monitoring of TG with LMWH anticoagulant therapy administration during pregnancy together with AT administration before and after delivery may improve the overall condition of pregnant women and the quality of their care.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)